跳至主要内容
临床试验/CTRI/2024/05/068049
CTRI/2024/05/068049尚未招募4 期

Comparison of efficacy , safety and cost effectiveness of Amlodipine versusS-Amlodipine in patients with Grade I and grade II hypertension- aprospective, Randomised controlled trial , 16-weeks Double Blind study. - NI

Indira Gandhi Government Medical College and Hospital, Nagpur.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients aged 18 to 75 years
  • 2. Diagnosed with grade I & II hypertension ( Systolic BP between 140-179 mmHg and/or Diastolic BP between 90-109 mmHg).
  • 3. Patients who are able to comply with the study protocol ,attend scheduled visits ,willingness to participate in the study and provide informed consent.
  • 4. OutPatient Department

排除标准

  • 1.Previous History of myocardial infarction , PTCA , CABG, angina pectoris or cerebrovascular accidents in the last 6 months .
  • 2.History of secondary or malignant hypertension
  • 3.History of congestive cardiac failure , cardiac arrhythmias, any other abnormalities in ECG.
  • 4.Patient with known significant respiratory conditions .
  • 5. Patient with known significant Neurological diseases , Coagulation disorders , metabolic or endocrine disorder (except Type 2 Diabetes Mellitus)
  • 6. Uncontrolled Diabetes Mellitus (fasting blood glucose more than 140 mg/dl ) or diabetic edema or Type 2 Diabetes Mellitus taking insulin or oral hypoglycemic drugs other than Metformin or sulfonylureas and more than one sulfonylureas.
  • 7. Patient with Liver or Kidney disorder
  • 8. Patients who may develop edema feet by concomitant drug at screening :
  • a. Drugs that constrict intra renal blood vessels (eg. NSAIDS , Cyclosporine etc.)
  • b. Drugs that dilate arterioles (eg .vasodilators etc)
  • c. Drugs that increase sodium reabsorption in the kidneys (eg steroids)
  • d.Drugs that damage capillaries (eg interleukins 2 )
  • e. Glitazone based drugs for diabetes
  • 9.Known Hypersensitivity to CCBs.
  • 10. Patients with psychiatric disorder .
  • 11.Those who are taking the drugs that may cause drug interactions.
  • a.Drugs that may change the plasma concentration of amlodipine (eg.CYP3A4 inducers -Rifampicin , St.johns wort)
  • b.Drugs that may increase the antihypertensive action {(eg. other antihypertensives -CCBs , Beta blockers , ACEi , ARBs, Alpha blockers , diuretics , Ntg ),(TCAs- Amitriptyline , desipramine, imipramine, nortriptyline, protriptyline, trimipramine ),nitrate formulations ,baclofen , pioglitazone , sildenafil etc.}
  • c. Systemic corticosteroids ( fluocinolone , triamcinolone) etc . : Local steroid application allowed.
  • d.Drugs that may increase the inhibitory action of muscle contraction .( eg-antiarrhythmics -amiodarone, quinidine) etc.
  • e.Drugs that may cause ventricular spasms (eg. intravenous administration of dantrolene and verapamil)
  • f.Drugs that may increase the risk of hypotension (eg CYP3A4 inhibitors -clarithromycin ) etc.
  • 12.Patients with a history of malignancy within the last 5 years.
  • 13. Pregnant and lactating women or the women in the reproductive age group not practicing the effevtive means of contraception
  • 14.Patients with known alcohol or drug abuse and any condition .
  • 15.Patients in inpatient department.
  • 16. Known case of immunodeficiency
  • 17.Age less than 18 years and greater than 75 years
  • 18.Participation in another clinical trial.

研究者

发起方
Indira Gandhi Government Medical College and Hospital, Nagpur.

相似试验